Organization
Ampio Pharmaceuticals
8 clinical trials
Clinical trial
A Randomized, Placebo-Controlled, Parallel, Double-Masked Study to Evaluate the Efficacy and Safety of Two Doses of Oral Optina™ in Adult Patients With Diabetic Macular EdemaStatus: Completed, Estimated PCD: 2014-10-30
Clinical trial
A Randomized, Double-Blinded, Placebo-Controlled Phase II Study to Evaluate the Safety and Efficacy of Inhaled Ampion in Adults With Respiratory Distress Due to COVID-19Status: Terminated, Estimated PCD: 2022-02-16
Clinical trial
An Open Label Extension Study to Assess the Safety of Long-Term Treatment With a 4 mL Intra-Articular Injection of Ampion in Adults With Pain Due to Severe Osteoarthritis of the KneeStatus: Terminated, Estimated PCD: 2018-10-04
Clinical trial
A Prospective Phase 1/2 Study to Evaluate the Safety and Exploratory Efficacy of Three Intra-articular Injections of Ampion™ (4 mL) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2015-10-01
Clinical trial
A Randomized, Double-Blinded, Placebo Controlled Phase II Study to Evaluate the Safety and Efficacy of IV Ampion in Adult COVID-19 Patients Requiring Oxygen SupplementationStatus: Terminated, Estimated PCD: 2022-02-07
Clinical trial
A Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Three Intra-articular Injections of Ampion™ (4 mL) Administered Two Weeks Apart in Adults With Pain Due to Osteoarthritis of the KneeStatus: Completed, Estimated PCD: 2015-04-01
Clinical trial
A Randomized, Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of an Intra-Articular Injection of Ampion in Adults With Pain Due to Severe Osteoarthritis of the Knee.Status: Terminated, Estimated PCD: 2021-07-13
Clinical trial
A Randomized, Double-Blinded, Placebo-Controlled Phase I Study to Evaluate the Safety and Efficacy of Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)Status: Completed, Estimated PCD: 2021-12-22